Sfoglia per Autore
Sindrome anti-sintetasi: due casi di anti-EJ (anti-glycyl-tRNAsintetasi)
2015-01-01 Giannini, Margherita; D'Abbicco, Dario; Amati, A.; Rinaldi, Angela; Righetti, Giulia; Fornaro, Marco; Lacarpia, Nunzia; Lapadula, Giovanni; Iannone, Florenzo
AB0041 Serum Amyloid A Stimulates The Induction of Inflammatory Mediators in Monocytes from Behçet's Disease Patients: A Proof of Concept Study
2016-01-01 Lopalco, G.; Lucherini, O. M.; Cantarini, L.; Lopalco, A.; Vitale, Antonio; Venerito, V.; Chialà, Angela; Fornaro, M.; Anelli, M. G.; Scioscia, C.; Cacciapaglia, F.; Natuzzi, D.; Lapadula, G.; Iannone, Florenzo
AB0836 Drug retention rate of the first tnf inhibitor in radiographic and non radiographic axial spondyloarthritis: data from a multicenter study
2018-01-01 Lopalco, G.; Venerito, V.; Cantarini, L.; Emmi, G.; Salaffi, F.; Tafuri, S.; Bianchi, F. P.; Di Carlo, M.; Gentileschi, S.; Di Scala, G.; Nivuori, M.; Perniola, S.; Fornaro, M.; Anelli, M. G.; Cacciapaglia, F.; Scioscia, C.; Fabiani, C.; Galeazzi, M.; Lapadula, G.; Iannone, Florenzo
THU0153 The effect of 5-years b-dmards treatment on different 10-years cardiovascular risk scores applied in rheumatoid arthritispatients
2018-01-01 Cacciapaglia, F.; Fornaro, M.; Renna, D.; Cafarelli, F.; Lopalco, G.; Anelli, M. G.; Scioscia, C.; Lapadula, G.; Iannone, Florenzo
Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid arthritis, Spondyloarthritis and Psoriatic arthritis in real-world settings
2018-01-01 Iannone, Florenzo; Salaffi, Fausto; Fornaro, Marco; Di Carlo, Marco; Gentileschi, Stefano; Cantarini, Luca; Lopalco, Giuseppe
Lipids and atherogenic indices fluctuation in rheumatoid arthritis patients on long-term tocilizumab treatment
2018-01-01 Cacciapaglia, Fabio; Anelli, Maria Grazia; Rinaldi, Angela; Fornaro, Marco; Lopalco, Giuseppe; Scioscia, Crescenzio; Lapadula, Giovanni; Iannone, Florenzo
Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus
2019-01-01 Fornaro, Marco; Coladonato, Laura; Venerito, Vincenzo; Cacciapaglia, Fabio; Lopalco, Giuseppe; Iannone, Florenzo
Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases
2019-01-01 Bettiol, Alessandra; Lopalco, Giuseppe; Emmi, Giacomo; Cantarini, Luca; Urban, Maria Letizia; Vitale, Antonio; Denora, Nunzio; Lopalco, Antonio; Cutrignelli, Annalisa; Lopedota, Angela; Venerito, Vincenzo; Fornaro, Marco; Vannacci, Alfredo; Rigante, Donato; Cimaz, Rolando; Iannone, Florenzo
AB0245 PREDICTORS OF BIOLOGIC THERAPY DISCONTINUATION IN RHEUMATOID ARTHRITIS PATIENTS AFTER REMISSION ACHIEVEMENT: A MONOCENTRIC OBSERVATIONAL STUDY FROM BIOLOGIC APULIAN REGISTRY (BIOPURE)
2019-01-01 Fornaro, Marco; Cacciapaglia, Fabio; Lopalco, Giuseppe; Venerito, Vincenzo; Schiraldi, Sante; Renna, Daniela; Laselva, Gaetana; Scioscia, Crescenzio; Lapadula, Giovanni; Iannone, Florenzo
Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the biologic apulian registry (BIOPURE)
2019-01-01 Carlino, G.; Fornaro, M.; Santo, L.; Bucci, R.; Semeraro, A.; Quarta, L.; D'Onofrio, F.; Marsico, A.; Zuccaro, C.; Falappone, P. C.; Mazzotta, D.; Cantatore, F. P.; Muratore, M.; Iannone, F.
Influence of changes in cholesterol levels and disease activity on the 10 years cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients
2019-01-01 Fornaro, Marco; Cacciapaglia, Fabio; Venerito, Vincenzo; Lopalco, Giuseppe; Iannone, Florenzo
A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis
2019-01-01 Venerito, Vincenzo; Lopalco, Giuseppe; Cacciapaglia, Fabio; Fornaro, Marco; Iannone, Florenzo
Paradoxical Pustular Psoriasis in a Patient with Psoriatic Arthritis on Secukinumab Treatment
2020-01-01 Abbruzzese, A.; Venerito, V.; Lopalco, G.; Fornaro, M.; Giannotta, M.; Iannone, F.
Erratum: Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus (Rheumatology (2020) 59 (1188) DOI: 10.1093/rheumatology/kez442)
2020-01-01 Fornaro, M.; Coladonato, L.; Venerito, V.; Cacciapaglia, F.; Lopalco, G.; Iannone, F.
Cardiovascular risk estimation with 5 different algorithms before and after 5 years of bDMARD treatment in rheumatoid arthritis
2020-01-01 Cacciapaglia, F.; Fornaro, M.; Venerito, V.; Perniola, S.; Urso, L.; Iannone, F.
Long-term efficacy of adding intravenous immunoglobulins as treatment of refractory dysphagia related to myositis: a retrospective analysis
2020-01-01 Giannini, Margherita; Fiorella, Maria Luisa; Tampoia, Marilina; Girolamo, Francesco; Fornaro, Marco; Amati, Angela; Lia, Anna; Abbracciavento, Letizia; D'Abbicco, Dario; Iannone, Florenzo
The Impact of Biologic Drugs on High-Density Lipoprotein Cholesterol Efflux Capacity in Rheumatoid Arthritis Patients
2020-01-01 Cacciapaglia, Fabio; Perniola, Simone; Venerito, Vincenzo; Anelli, Maria Grazia; Härdfeldt, Jennifer; Fornaro, Marco; Moschetta, Antonio; Iannone, Florenzo
Comorbid fibromyalgia impairs the effectiveness of biologic drugs in patients with psoriatic arthritis
2020-01-01 Iannone, F.; Nivuori, M.; Fornaro, M.; Venerito, V.; Cacciapaglia, F.; Lopalco, G.
Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes
2020-01-01 Vitale, A.; Cavalli, G.; Ruscitti, P.; Sota, J.; Colafrancesco, S.; Priori, R.; Valesini, G.; Argolini, L. M.; Baldissera, E.; Bartoloni, E.; Cammelli, D.; Canestrari, G.; Cavallaro, E.; Massaro, M. G.; Cipriani, P.; De Marchi, G.; De Vita, S.; Emmi, G.; Frassi, M.; Gerli, R.; Gremese, E.; Iannone, F.; Fornaro, M.; Paladini, A.; Lopalco, G.; Manna, R.; Mathieu, A.; Montecucco, C.; Mosca, M.; Piazza, I.; Piga, M.; Pontikaki, I.; Romano, M.; Rossi, S.; Rossini, M.; Silvestri, E.; Stagnaro, C.; Talarico, R.; Frediani, B.; Tincani, A.; Viapiana, O.; Vitiello, G.; Galozzi, P.; Sfriso, P.; Gaggiano, C.; Grosso, S.; Rigante, D.; Dagna, L.; Giacomelli, R.; Cantarini, L.
Phosphorylated signal transducer and activator of transcription 3 (pSTAT3) is highly expressed in CD14+ circulating cells of scleroderma patients
2020-01-01 Cacciapaglia, F.; Perniola, S.; Perniola, S.; Urso, L.; Fornaro, M.; Iannone, F.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Sindrome anti-sintetasi: due casi di anti-EJ (anti-glycyl-tRNAsintetasi) | 1-gen-2015 | Giannini, Margherita; D'Abbicco, Dario; Amati, A.; Rinaldi, Angela; Righetti, Giulia; Fornaro, Marco; Lacarpia, Nunzia; Lapadula, Giovanni; Iannone, Florenzo | |
| AB0041 Serum Amyloid A Stimulates The Induction of Inflammatory Mediators in Monocytes from Behçet's Disease Patients: A Proof of Concept Study | 1-gen-2016 | Lopalco, G.; Lucherini, O. M.; Cantarini, L.; Lopalco, A.; Vitale, Antonio; Venerito, V.; Chialà, Angela; Fornaro, M.; Anelli, M. G.; Scioscia, C.; Cacciapaglia, F.; Natuzzi, D.; Lapadula, G.; Iannone, Florenzo | |
| AB0836 Drug retention rate of the first tnf inhibitor in radiographic and non radiographic axial spondyloarthritis: data from a multicenter study | 1-gen-2018 | Lopalco, G.; Venerito, V.; Cantarini, L.; Emmi, G.; Salaffi, F.; Tafuri, S.; Bianchi, F. P.; Di Carlo, M.; Gentileschi, S.; Di Scala, G.; Nivuori, M.; Perniola, S.; Fornaro, M.; Anelli, M. G.; Cacciapaglia, F.; Scioscia, C.; Fabiani, C.; Galeazzi, M.; Lapadula, G.; Iannone, Florenzo | |
| THU0153 The effect of 5-years b-dmards treatment on different 10-years cardiovascular risk scores applied in rheumatoid arthritispatients | 1-gen-2018 | Cacciapaglia, F.; Fornaro, M.; Renna, D.; Cafarelli, F.; Lopalco, G.; Anelli, M. G.; Scioscia, C.; Lapadula, G.; Iannone, Florenzo | |
| Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid arthritis, Spondyloarthritis and Psoriatic arthritis in real-world settings | 1-gen-2018 | Iannone, Florenzo; Salaffi, Fausto; Fornaro, Marco; Di Carlo, Marco; Gentileschi, Stefano; Cantarini, Luca; Lopalco, Giuseppe | |
| Lipids and atherogenic indices fluctuation in rheumatoid arthritis patients on long-term tocilizumab treatment | 1-gen-2018 | Cacciapaglia, Fabio; Anelli, Maria Grazia; Rinaldi, Angela; Fornaro, Marco; Lopalco, Giuseppe; Scioscia, Crescenzio; Lapadula, Giovanni; Iannone, Florenzo | |
| Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus | 1-gen-2019 | Fornaro, Marco; Coladonato, Laura; Venerito, Vincenzo; Cacciapaglia, Fabio; Lopalco, Giuseppe; Iannone, Florenzo | |
| Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases | 1-gen-2019 | Bettiol, Alessandra; Lopalco, Giuseppe; Emmi, Giacomo; Cantarini, Luca; Urban, Maria Letizia; Vitale, Antonio; Denora, Nunzio; Lopalco, Antonio; Cutrignelli, Annalisa; Lopedota, Angela; Venerito, Vincenzo; Fornaro, Marco; Vannacci, Alfredo; Rigante, Donato; Cimaz, Rolando; Iannone, Florenzo | |
| AB0245 PREDICTORS OF BIOLOGIC THERAPY DISCONTINUATION IN RHEUMATOID ARTHRITIS PATIENTS AFTER REMISSION ACHIEVEMENT: A MONOCENTRIC OBSERVATIONAL STUDY FROM BIOLOGIC APULIAN REGISTRY (BIOPURE) | 1-gen-2019 | Fornaro, Marco; Cacciapaglia, Fabio; Lopalco, Giuseppe; Venerito, Vincenzo; Schiraldi, Sante; Renna, Daniela; Laselva, Gaetana; Scioscia, Crescenzio; Lapadula, Giovanni; Iannone, Florenzo | |
| Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the biologic apulian registry (BIOPURE) | 1-gen-2019 | Carlino, G.; Fornaro, M.; Santo, L.; Bucci, R.; Semeraro, A.; Quarta, L.; D'Onofrio, F.; Marsico, A.; Zuccaro, C.; Falappone, P. C.; Mazzotta, D.; Cantatore, F. P.; Muratore, M.; Iannone, F. | |
| Influence of changes in cholesterol levels and disease activity on the 10 years cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients | 1-gen-2019 | Fornaro, Marco; Cacciapaglia, Fabio; Venerito, Vincenzo; Lopalco, Giuseppe; Iannone, Florenzo | |
| A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis | 1-gen-2019 | Venerito, Vincenzo; Lopalco, Giuseppe; Cacciapaglia, Fabio; Fornaro, Marco; Iannone, Florenzo | |
| Paradoxical Pustular Psoriasis in a Patient with Psoriatic Arthritis on Secukinumab Treatment | 1-gen-2020 | Abbruzzese, A.; Venerito, V.; Lopalco, G.; Fornaro, M.; Giannotta, M.; Iannone, F. | |
| Erratum: Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus (Rheumatology (2020) 59 (1188) DOI: 10.1093/rheumatology/kez442) | 1-gen-2020 | Fornaro, M.; Coladonato, L.; Venerito, V.; Cacciapaglia, F.; Lopalco, G.; Iannone, F. | |
| Cardiovascular risk estimation with 5 different algorithms before and after 5 years of bDMARD treatment in rheumatoid arthritis | 1-gen-2020 | Cacciapaglia, F.; Fornaro, M.; Venerito, V.; Perniola, S.; Urso, L.; Iannone, F. | |
| Long-term efficacy of adding intravenous immunoglobulins as treatment of refractory dysphagia related to myositis: a retrospective analysis | 1-gen-2020 | Giannini, Margherita; Fiorella, Maria Luisa; Tampoia, Marilina; Girolamo, Francesco; Fornaro, Marco; Amati, Angela; Lia, Anna; Abbracciavento, Letizia; D'Abbicco, Dario; Iannone, Florenzo | |
| The Impact of Biologic Drugs on High-Density Lipoprotein Cholesterol Efflux Capacity in Rheumatoid Arthritis Patients | 1-gen-2020 | Cacciapaglia, Fabio; Perniola, Simone; Venerito, Vincenzo; Anelli, Maria Grazia; Härdfeldt, Jennifer; Fornaro, Marco; Moschetta, Antonio; Iannone, Florenzo | |
| Comorbid fibromyalgia impairs the effectiveness of biologic drugs in patients with psoriatic arthritis | 1-gen-2020 | Iannone, F.; Nivuori, M.; Fornaro, M.; Venerito, V.; Cacciapaglia, F.; Lopalco, G. | |
| Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes | 1-gen-2020 | Vitale, A.; Cavalli, G.; Ruscitti, P.; Sota, J.; Colafrancesco, S.; Priori, R.; Valesini, G.; Argolini, L. M.; Baldissera, E.; Bartoloni, E.; Cammelli, D.; Canestrari, G.; Cavallaro, E.; Massaro, M. G.; Cipriani, P.; De Marchi, G.; De Vita, S.; Emmi, G.; Frassi, M.; Gerli, R.; Gremese, E.; Iannone, F.; Fornaro, M.; Paladini, A.; Lopalco, G.; Manna, R.; Mathieu, A.; Montecucco, C.; Mosca, M.; Piazza, I.; Piga, M.; Pontikaki, I.; Romano, M.; Rossi, S.; Rossini, M.; Silvestri, E.; Stagnaro, C.; Talarico, R.; Frediani, B.; Tincani, A.; Viapiana, O.; Vitiello, G.; Galozzi, P.; Sfriso, P.; Gaggiano, C.; Grosso, S.; Rigante, D.; Dagna, L.; Giacomelli, R.; Cantarini, L. | |
| Phosphorylated signal transducer and activator of transcription 3 (pSTAT3) is highly expressed in CD14+ circulating cells of scleroderma patients | 1-gen-2020 | Cacciapaglia, F.; Perniola, S.; Perniola, S.; Urso, L.; Fornaro, M.; Iannone, F. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile